Karl E. Hellstrom
34Patents
21h-index
40Co-inventors
85Inventor score
Filing activity: Dec 21, 1984 → Feb 17, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5869045A | Antibody conjugates reactive with human carcinomas | Chemistry; Metallurgy | 194 | Expired |
| US5171665A | Monoclonal antibody to novel antigen associated with human tumors | Emerging Cross-Sectional Technologies | 122 | Expired |
| US5134075A | Monoclonal antibody to novel antigen associated with human tumors | Emerging Cross-Sectional Technologies | 110 | Expired |
| US4918164A | Tumor immunotherapy using anti-idiotypic antibodies | Emerging Cross-Sectional Technologies | 75 | Expired |
| US5262177A | Recombinant viruses encoding the human melanoma-associated antigen | Physics | 61 | Expired |
| US5980896A | Antibodies reactive with human carcinomas | Chemistry; Metallurgy | 57 | Expired |
| US5811098A | Antibodies to HER4, human receptor tyrosine kinase | Physics | 51 | Expired |
| US5091178A | Tumor therapy with biologically active anti-tumor antibodies | Emerging Cross-Sectional Technologies | 45 | Expired |
| US5242824A | Monoclonal antibody to human carcinomas | Chemistry; Metallurgy | 42 | Expired |
| US6770445B1 | Methods and compositions for diagnosing carcinomas | Physics | 41 | Expired |
| US5354847A | Chimeric antibody with specificity to human tumor antigen | Chemistry; Metallurgy | 41 | Expired |
| US4997913A | pH-sensitive immunoconjugates and methods for their use in tumor therapy | Emerging Cross-Sectional Technologies | 39 | Expired |
| US6734172B2 | Surface receptor antigen vaccines | Human Necessities | 35 | Expired |
| US4906562A | Monocolonal antibodies and antigen for human non-small cell lung carcinomas | Emerging Cross-Sectional Technologies | 33 | Expired |
| US5840854A | Monoclonal antibody BR110 and uses thereof | Chemistry; Metallurgy | 32 | Expired |
| US5091177A | Monoclonal antibodies for treatment of human non-small cell lung carcinomas | Emerging Cross-Sectional Technologies | 30 | Expired |
| US5491088A | Monoclonal antibody BR 96 and chimeric monoclonal antibodies having the variable region of MAB BR96, which bind to a variant of ley antigen on human carcimona cells | Chemistry; Metallurgy | 29 | Expired |
| US5141742A | Vaccines against melanoma | Human Necessities | 28 | Expired |
| US4737579A | Monoclonal antibodies for human non-small cell lung carinomas | Emerging Cross-Sectional Technologies | 25 | Expired |
| US5165922A | Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy | Human Necessities | 24 | Expired |
| US4935495A | Monoclonal antibodies to the L6 glycolipid antigenic determinant found on human non-small cell lung carcinomas | Emerging Cross-Sectional Technologies | 23 | Expired |
| US5597707A | Tumor associated antigen recognized by the murine monoclonal antibody L6, its oligonucleotide sequence and methods for their use | Physics | 17 | Expired |
| US7547681B2 | Surface receptor antigen vaccines | Human Necessities | 12 | Expired |
| US5614610A | Tumor immunotherapy using anti-idiotypic antibodies | Chemistry; Metallurgy | 11 | Expired |
| US5185432A | Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas | Human Necessities | 11 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.